Chemical degradation kinetics of fibrates: bezafibrate, ciprofibrate and fenofibrate

by Marcelo Antonio de Oliveira, Gerliane Damázio da Silva, Michele Soares Tacchi Campos

Effet des fibrates sur la synthèse périphérique et le métabolisme hépatique de la bilirubine, un endobiotique aux propriétés anti-oxydantes et athéro-protectrice

by El Husseini, Diala
Published 2009

Combined statin-fibrate therapy-induced rhabdomyolysis: Case report

by Jozić Tanja L., Terzić Branka M., Mitrović Predrag M., Kostić Jasminka D., Milanov Marko Z., Stojanović Milena M., Ašanin Milika R.
Published 2014-01-01

Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention

by Zhou Yu-Hao, Ye Xiao-Fei, Yu Fei-Fei, Zhang Xiao, Qin Ying-Yi, Lu Jian, He Jia
Published 2013-01-01

AUTOIMMUNE DISEASES AND ATHEROSCLEROSIS - PROBLEMS OF TREATMENT

by I. V. Shirinskiy, O. A. Polovnikova, V. S. Shirinskiy
Published 2012-05-01

Hypolipemiant Treatment: Making the Right Choice for Osteoporotic Patients

by Șipoș Remus, Șuș Ioana, Pap Zsuzsanna, Szalai Anna Szidónia, Gabor Anamaria Victoria, Pávai Z, Brînzaniuc Klara
Published 2013-02-01

Incidence, predictors and patterns of care of patients with very severe hypertriglyceridemia in Ontario, Canada: a population-based cohort study

by Amanda J. Berberich, Alexandra M. Ouédraogo, Salimah Z. Shariff, Robert A. Hegele, Kristin K. Clemens
Published 2021-09-01

The Effects of Statin and Fibrate Drugs on Cholesterol Metabolism and Steroid Production in Two Fish Species

by Al-Habsi, Aziz
Published 2014

Hepatic PPARα function and lipid metabolic pathways are dysregulated in polymicrobial sepsis

by Lise Van Wyngene, Tineke Vanderhaeghen, Steven Timmermans, Jolien Vandewalle, Kelly Van Looveren, Jolien Souffriau, Charlotte Wallaeys, Melanie Eggermont, Sam Ernst, Evelien Van Hamme, Amanda Gonçalves, Guy Eelen, Anneleen Remmerie, Charlotte L Scott, Caroline Rombouts, Lynn Vanhaecke, Liesbet De Bus, Johan Decruyenaere, Peter Carmeliet, Claude Libert
Published 2020-02-01

Associação de medicamentos: estatinas e fibratos Combination of drugs: statins and fibrates

by Hermes Toros Xavier
Published 2005-10-01

Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits

by Cristóbal Flores-Castillo, María Luna-Luna, Elizabeth Carreón-Torres, Victoria López-Olmos, Sara Frías, Marco Antonio Juárez-Oropeza, Martha Franco, José Manuel Fragoso, Gilberto Vargas-Alarcón, Óscar Pérez-Méndez
Published 2019-05-01

Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study

by Francis Gordon A, Frohlich Jiri, Taraboanta Catalin, Al-Sarraf Ahmad, Sandhu Supna
Published 2011-09-01

Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunities

by Watts Gerald F
Published 2001-05-01

Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body...

by Medel Octavio, Hernández Ismael, Salinas Saul, Vazquez Cuauhtémoc, Ramírez Erika, Jiménez Sergio, Hernández Ma, Florenzano Fernando, Saavedra Victor, Reyes Eliana, Machado Carlos, Oliveira José, Torres Kerginaldo, Rabelo Lísia, Neto Abrahão, Filho José, Rengifo Hector, Stockins Benjamín, Aguilar-Salinas Carlos A, Assis-Luores-Vale Andréia, Moreno Ricardo, Lugo Paula, Alvarado Ricardo, Mehta Roopa, Gutierrez Victor, Gómez Pérez Francisco J
Published 2004-07-01

Étude des fibrates en tant qu'agents stimulateurs de la synthèse des cétones, des substrats énergétiques pour le cerveau vieillissant

by Tremblay-Mercier, Jennifer
Published 2008

Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies

by Magda Dubińska-Magiera, Marta Migocka-Patrzałek, Damian Lewandowski, Małgorzata Daczewska, Krzysztof Jagla
Published 2021-05-01

Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study

by Mohammadreza Bordbar, Renée de Mutsert, Melike Cevval, Frits R. Rosendaal, J. Wouter Jukema, Willem M. Lijfering
Published 2021-06-01

Comparative analysis of the use of lipid modifying agents in the Republic of Serbia and Nordic countries in the period 2015-2017

by Martić Nikola B., Zečević Dragan D., Đurđević Milena V., Milijašević Dragana S., Tomić Nataša Z., Lalić-Popović Mladena N., Todorović Nemanja B., Medin Danilo V., Mićanović Branimir B., Milijašević Boris Ž.
Published 2020-01-01

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?

by Tenenbaum Alexander, Fisman Enrique Z
Published 2004-12-01

LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia

by Ariel Brautbar, Salim S. Virani, John Belmont, Vijay Nambi, Peter H. Jones, Christie M. Ballantyne
Published 2012-03-01